Home > Healthcare > Medical Devices > Therapeutic Devices > Vascular Closure Device Market

Vascular Closure Device Market Share

Report ID: GMI1967
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Vascular Closure Device Market Share

The market is characterized by the presence of several key players and a focus on technological innovation and strategic partnerships. These companies invest significantly in research and development to introduce advanced VCD technologies, including bioabsorbable devices, hemostatic plugs, and closure systems with enhanced safety features. Market competition is intensified by stringent regulatory requirements and the need for continuous product enhancements to meet evolving clinical needs. Strategic initiatives such as mergers, acquisitions, and collaborations are common strategies employed by key players to strengthen their market position and expand their geographic footprint. Emerging players also play a crucial role in the market by introducing innovative solutions aimed at improving procedural outcomes and patient care in vascular access management.

Vascular Closure Device Market Companies

Prominent players operating in the vascular closure device industry include:

Abbott Laboratories
Advanced Vascular Dynamics
Biotronik SE & Co. KG
Cardinal Health, Inc.
Ensite Vascular
Haemonetics Corporation (cardiva Medical Inc.)
Marine Polymer Technologies
Medtronic, Plc
Merit Medical Systems
REX MEDICAL
Teleflex Incorporated
Terumo Corporation
Tricol Biomedical
TZ Medical
Vasorum Limited

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Global vascular closure device industry was valued at USD 1.7 billion in 2023 and is anticipated to register 6.3% CAGR between 2024 and 2032, driven by technological advancements in vascular closure devices and the rising popularity of minimally invasive procedures.

The active segment in the market was valued at USD 987.7 million in 2023, owing to the advanced technologies, such as bioabsorbable materials and improved sealing mechanisms.

North America vascular closure device market is anticipated to grow at 6.1% CAGR between 2024 – 2032 due to the large number of diagnostic and interventional cardiovascular procedures.

Abbott Laboratories, Advanced Vascular Dynamics, Biotronik SE & Co. KG, Cardinal Health, Inc., Ensite Vascular, Haemonetics Corporation (cardiva Medical Inc.), Marine Polymer Technologies, Medtronic, Plc, and Merit Medical Systems, among others.